Author: Tely Publisher

Introduction

While Chile offers a great chance for MedTech and Biopharma companies to innovate while keeping costs in check, the path to success is fraught with challenges that require strategic navigation.

With a regulatory framework that supports swift approvals and a diverse patient population, Chile stands out as a strategic location for first-in-human studies.

Yet, navigating local regulations can be daunting for sponsors, often leading to delays and increased costs, especially when it comes to engaging patients effectively.

What strategies can sponsors adopt to truly harness Chile’s advantages for successful and cost-effective clinical trials?

Understand Early Phase Clinical Trials in Chile

Initial phase clinical evaluations, particularly first-in-human (FIH) studies, are pivotal in the drug development process, shaping the future of innovative therapies. In this country, these studies are backed by a strong regulatory framework supervised by the Instituto de Salud Pública (ISP), which guarantees adherence to ICH-GCP standards. The approval process typically lasts between 30 to 60 days, with the ISP assessing applications within 30 business days. Conducting an affordable clinical trial in Chile offers a cost advantage of up to 40% compared to the U.S., positioning it as a strategic choice for MedTech and Biopharma startups.

Essential elements to consider are:

• Regulatory Framework: The ISP governs clinical trials, ensuring adherence to national and international guidelines. Familiarity with these regulations is essential for successful execution of the study.
• Cost Efficiency: The reduced operational expenses in the region enable sponsors to allocate resources more effectively, which is essential for startups functioning with constrained budgets. This cost advantage can significantly enhance the financial viability of affordable clinical trial Chile during early phase studies.
• Diverse Patient Population: The varied demographics of the country enhance recruitment potential, offering access to a broad spectrum of participants for research studies. This diversity accelerates enrollment and significantly enhances the representativeness of study results, a critical factor in clinical research.

By comprehending these components and utilizing insights from bioaccess®’s Global Trial Accelerators™, sponsors can enhance their readiness for the challenges and opportunities that early phase studies present in the region, ultimately driving their research towards success.

Navigate Regulatory Requirements for Clinical Trials

To successfully conduct clinical studies in Chile, sponsors must adeptly navigate a complex regulatory landscape established by the Instituto de Salud Pública (ISP) and the Agencia Nacional de Medicamentos (ANAMED). Here’s a step-by-step approach:

1. Prepare Documentation: Gather all essential documents, including the research protocol, informed consent forms, and investigator brochures. Ensure that these documents adhere to ICH-GCP standards, which are vital for upholding the integrity and quality of the study.
2. Submit Application: Submit your clinical study application to the ISP, including all compiled documents and any additional information requested by the regulatory body. This submission is crucial for kickstarting the approval process.
3. Approval Timeline: The average duration for approval is approximately 30 business days, significantly faster than many other regions. The ISP has streamlined the research approval process, minimizing bureaucratic delays by over 30%. This represents a major advantage for conducting studies in Chile, enabling sponsors to commence trials more swiftly, particularly advantageous for First-in-Human (FIH) evaluations.
4. Ethics Committee Review: Concurrently, submit your research for evaluation by an accredited ethics committee (EC). This step is vital for guaranteeing participant safety and ethical adherence, as only accredited ECs can approve research protocols. Compliance with the Declaration of Helsinki and local ethical standards is mandatory.
5. Post-Approval Compliance: Once approved, you’ll need to keep up with regular reporting to the ISP and follow any conditions laid out during the approval process. Additionally, after receiving ISP approval, it’s essential to notify ANAMED to ensure all regulatory steps are completed.
6. Develop Recruitment Strategy: A robust recruitment plan is essential for enrolling participants in research initiatives. Understanding the socio-political context in the region, including potential barriers to patient access, can enhance recruitment efforts and ensure a diverse participant pool. Leveraging bioaccess®’s expertise in early feasibility studies can further streamline this process, ensuring that sponsors can effectively engage with potential participants.

By adhering to these procedures and leveraging bioaccess®’s offerings, sponsors can optimize their regulatory submissions and improve the chances of a successful study launch in the region, positioning themselves for success in the dynamic Latin American market.

Implement Strategies for Successful Trial Execution

Navigating the complex regulatory landscape in Chile can be daunting for sponsors, but adopting an affordable clinical trial Chile strategy can pave the way for successful medical research implementation. Here are key strategies to consider:

1. Site Selection: Prioritize research locations with a proven track record in early phase studies. Assess their experience, infrastructure, and patient access to ensure they can meet the specific requirements of your study. Considering that over 96% of clinical studies in Chile are financed by external pharmaceutical companies, selecting sites with established relationships can enhance recruitment and retention for affordable clinical trial Chile. Utilizing bioaccess®’s pre-negotiated site agreements can result in substantial cost reductions of $25K per patient, improving the overall feasibility of your study.
2. Risk-Based Monitoring: Implement a strategy focused on high-risk areas of the study by allocating resources effectively. This approach allows for early identification of potential issues, facilitating timely interventions and ensuring compliance with ICH-GCP standards. Reports suggest that effective risk management can greatly enhance research outcomes by addressing challenges proactively.
3. Training and Support: Providing ongoing support during the study not only boosts data quality but also keeps participants safe, which is essential for preserving the integrity of the research and fulfilling regulatory expectations. Bioaccess® offers tailored training programs that align with local regulations, ensuring that your team is well-prepared.
4. Data Management: Utilize robust data management systems to ensure accurate and timely data collection. This is crucial for preserving study integrity and enabling regulatory submissions, especially considering the average response time of 15 days from the Chilean Institute of Public Health for registration data. With bioaccess®, you can benefit from advanced data management solutions that streamline the process and improve efficiency.
5. Communication: Establish clear communication channels among all stakeholders, including sponsors, investigators, and regulatory bodies. Regular updates and feedback loops can help address challenges promptly, ensuring that all parties are aligned and informed throughout the research process. Bioaccess® facilitates effective communication through its Global Trial Accelerators™, providing essential insights and market access strategies tailored for MedTech and Biopharma innovators in Latin America.

By embracing these strategies, sponsors not only enhance their study outcomes but also contribute to the advancement of affordable clinical trial Chile in healthcare.

Enhance Patient Recruitment and Retention Strategies

Despite the critical importance of patient enrollment and retention, many studies in Chile struggle to engage participants effectively in affordable clinical trial settings. Here are targeted strategies to enhance these processes:

1. Community Engagement: Actively engage with local communities to raise awareness about clinical trials. Utilize local media, community events, and partnerships with healthcare providers to effectively reach potential participants. This approach fosters trust and encourages participation, as evidenced by the strong doctor-patient relationships prevalent in the region.
2. Digital Outreach: Leverage digital platforms for recruitment campaigns. Social media, online forums, and patient registries can efficiently identify and engage eligible candidates. Have you thought about using direct mail campaigns and targeted Facebook advertisements? One report indicates over 2.5 million impressions from Facebook ads alone, resulting in increased inquiries.
3. Incentives: Have you thought about offering incentives for participation, like travel reimbursements or health screenings? These incentives can motivate individuals to enroll and remain committed to the study, addressing potential barriers to participation.
4. Patient-Centric Approach: Design studies with the patient experience in mind. Streamline participation processes, offer clear information about the study, and ensure that participants feel appreciated and supported throughout their involvement. This approach can significantly enhance retention rates.
5. Retention Strategies: Implement proactive retention strategies, such as regular follow-ups and personalized communication. Address participant concerns promptly and provide updates on study progress to keep them engaged. Community Advisory Groups (CAGs) can play a vital role in maintaining participant engagement by fostering a sense of community and support.

Improving these strategies is not just beneficial; it is essential for the integrity and success of affordable clinical trial Chile.

Conclusion

Conducting affordable clinical trials in Chile presents a unique opportunity for MedTech and Biopharma companies willing to tackle the complexities of early phase studies. Chile’s robust regulatory framework, cost efficiency, and diverse patient population provide strategic advantages that foster innovative research. Leveraging these factors is essential for achieving successful outcomes in clinical trials.

Key insights from this guide highlight the importance of:

1. Navigating regulatory requirements effectively
2. Implementing robust recruitment strategies
3. Ensuring compliance with ICH-GCP standards

Sponsors must adopt a structured approach to documentation, approval processes, and participant engagement to streamline operations and mitigate risks. Furthermore, embracing community engagement and digital outreach can improve patient recruitment and retention, which are crucial for the integrity of clinical trials.

In conclusion, the landscape for early phase clinical trials in Chile is not only favorable but also ripe with potential for those willing to adopt a strategic approach. By taking advantage of the cost-effective solutions and regulatory efficiencies available, sponsors can position themselves for success in the competitive field of clinical research. To thrive in this competitive landscape, stakeholders must act decisively, embracing the opportunities that lie ahead.

Frequently Asked Questions

What are early phase clinical trials, specifically first-in-human (FIH) studies?

Early phase clinical trials, particularly FIH studies, are critical in the drug development process as they evaluate the safety and efficacy of new therapies in humans for the first time.

What regulatory body oversees clinical trials in Chile?

The Instituto de Salud Pública (ISP) is the regulatory authority that governs clinical trials in Chile, ensuring compliance with national and international standards, including ICH-GCP guidelines.

How long does the approval process for clinical trials take in Chile?

The approval process typically lasts between 30 to 60 days, with the ISP assessing applications within 30 business days.

What are the cost advantages of conducting clinical trials in Chile compared to the U.S.?

Conducting clinical trials in Chile can offer a cost advantage of up to 40% compared to the U.S., making it a strategic choice for MedTech and Biopharma startups.

Why is the regulatory framework important for clinical trials in Chile?

The regulatory framework established by the ISP is essential for ensuring that clinical trials adhere to both national and international guidelines, which is crucial for the successful execution of studies.

How does the diverse patient population in Chile benefit clinical trials?

The varied demographics in Chile enhance recruitment potential, allowing access to a broad spectrum of participants. This diversity accelerates enrollment and improves the representativeness of study results, which is vital for clinical research.

How can sponsors prepare for early phase studies in Chile?

Sponsors can enhance their readiness for early phase studies by understanding the regulatory framework, leveraging cost efficiency, and utilizing insights from bioaccess®’s Global Trial Accelerators™ to navigate challenges and opportunities in the region.

List of Sources

1. Understand Early Phase Clinical Trials in Chile
   • Trends in clinical trials performed in Chile (https://scielo.cl/article_plus.php?pid=S0034-98872021000100110&tlng=en&lng=es)
   • Master Early Phase Clinical Trials in Chile: Key Strategies and Insights – cms.bioaccessla.com (https://cms.bioaccessla.com/blog/master-early-phase-clinical-trials-in-chile-key-strategies-and-insights)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOorZfdDWgLFN4scg4mpP4PN4GvW5AlH4oBlN3ZPu_u7GVhAZzokh)
2. Navigate Regulatory Requirements for Clinical Trials
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOoqAaIyhPOudE-3CnJ-2rG8iEkg32x2e8C9jKw8O98pAIF_Ci2N5)
   • Master Regulatory Compliance for Trials in Chi… | bioaccess® (https://bioaccessla.com/blog/master-regulatory-compliance-for-trials-in-chile-effectively)
   • Master FDA Accepted Clinical Trials in Chile: A Step-by-Step Tutorial | bioaccess® (https://bioaccessla.com/blog/master-fda-accepted-clinical-trials-in-chile-a-step-by-step-tutorial)
   • Clinical Trials in Latin America (https://languageconnections.com/clinical-trials-in-latin-america)
   • How to Conduct First-in-Human Trials in Chile: A Step-by-Step Guide | bioaccess® (https://bioaccessla.com/blog/how-to-conduct-first-in-human-trials-in-chile-a-step-by-step-guide)
3. Implement Strategies for Successful Trial Execution
   • Trends in clinical trials performed in Chile (https://scielo.cl/article_plus.php?pid=S0034-98872021000100110&tlng=en&lng=es)
   • Best Practices for Selecting Investigator Sites in Chile for Clinical Trials | bioaccess® (https://bioaccessla.com/blog/best-practices-for-selecting-investigator-sites-in-chile-for-clinical-trials)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOoo2lZFnkVetcBVZ7wGD75q2hgzL9HxCsd3fRjZ4_UyDRXJVOENx)
4. Enhance Patient Recruitment and Retention Strategies
   • Latin America: A Compelling Region To Conduct Your Clinical Trials (https://clinicalleader.com/doc/latin-america-a-compelling-region-to-conduct-your-clinical-trials-0001)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOopgWM_mePVImKyY_G0yLadVejeP-2EpQOKrCVwDv9_Hse-lRqX-)
   • Community Informed Recruitment: A Promising Method to Enhance Clinical Trial Participation (https://jpsmjournal.com/article/S0885-3924(23)00398-6/fulltext)
   • Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trial – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC12444702)

Introduction

While Chile offers enticing financial advantages for clinical research, the path to successful study execution is fraught with challenges that demand strategic navigation. Chile has emerged as a beacon for clinical research, particularly for first-in-human studies, with clinical trial costs being 30% to 75% lower than in the U.S. and Europe. This financial landscape allows startups to optimize their budgets and resources effectively.

Despite the financial advantages, many companies struggle to effectively manage the complexities of clinical trials in Chile. To truly harness the potential of Chile’s clinical research landscape, companies must not only recognize these challenges but also develop robust strategies to overcome them.

Understand the Financial Landscape of Clinical Trials in Chile

Chile stands out as a prime destination for clinical research, particularly for first-in-human studies, because the clinical trial cost in Chile is significantly lower compared to the U.S. and Europe. The clinical trial cost in Chile can be conducted at levels that are roughly 30% to 75% lower than in developed markets. Several key factors contribute to this cost efficiency:

• Lower Site Costs: Clinical research sites in Chile typically incur reduced overhead, resulting in lower fees for sponsors. This is particularly advantageous for startups looking to maximize their budgets.
• Government Incentives: The Chilean government actively supports clinical research through various incentives, including tax breaks and grants for innovative studies, which can further reduce overall study costs.
• Access to Funding: Startups can leverage regional venture capital and government funding programs specifically designed to support healthcare innovations, enhancing their financial viability.
• Regulatory Framework: Navigating the regulatory landscape can be daunting for many sponsors, often leading to delays and increased costs. Compliance with regional regulatory authorities such as the Instituto de Salud Pública (ISP) and adherence to ICH-GCP standards are essential for study approval. Understanding the submission pathways and approval timelines can significantly expedite the process.

When sponsors grasp these financial dynamics and regulatory requirements, they can really optimize their budgets and allocate resources effectively, ensuring they hit their first-in-human milestones without draining their capital reserves. This strategic approach not only facilitates faster study execution but also aligns with the regulatory frameworks established by local authorities, ensuring compliance and expediting the approval process. Have you considered how per-patient expenditures in LATAM, ranging from $15,000 to $35,000, compare to the $40,000 to $75,000 in the US/EU? This stark difference underscores the financial advantages of conducting studies, particularly considering the clinical trial cost in Chile. With insights from bioaccess®, MedTech startups can navigate these financial landscapes more effectively, ensuring successful study outcomes.

Implement Strategic Budgeting and Cost Management Techniques

To thrive in the competitive landscape of clinical trials in Chile, startups must master budgeting and cost management techniques:

• Detailed Budget Forecasting: Develop a comprehensive budget that encompasses all potential costs, including site fees, patient recruitment, and regulatory submissions. Historical data from previous studies can provide valuable insights for more accurate estimates. For instance, utilizing historical data can assist in forecasting expenses related to site payments and patient recruitment, which are essential for sustaining financial oversight. In Latin America, understanding the clinical trial cost in Chile, which can be 30% lower than in the US/EU, is crucial.
• Regular Budget Reviews: Have you considered implementing periodic budget reviews to identify variances and adjust forecasts accordingly? This proactive strategy aids in managing unexpected expenses and maintaining financial control. As operational burdens rise in 2024, startups may struggle to keep budgets on track without regular reviews, especially in a region where regulatory timelines can be significantly shorter.
• Negotiate Contracts: Engage in negotiations with vendors and service providers to secure favorable terms. The competitive landscape in Chile can be leveraged to obtain better pricing, which is crucial for startups managing the clinical trial cost in Chile on tight budgets. Comprehending a sponsor’s budget constraints can also aid in establishing equitable objectives and requests during discussions, especially when considering the clinical trial cost in Chile and the financial benefits of performing studies in Latin America.
• Utilize Cost-Effective Resources: Choose regional suppliers for clinical trial materials and services to minimize shipping costs and import taxes. Not only does this lower expenses, but it also supports the regional economy, creating a more sustainable operational model. Furthermore, using regional resources can improve compliance with regulatory authorities such as the Instituto de Salud Pública (ISP) and ensure adherence to ICH-GCP standards. Bioaccess® can assist in navigating these local resources effectively.

By implementing these strategies, startups can effectively manage their finances. It keeps studies within budget while navigating the regulatory landscape set by authorities like the ISP and adhering to ICH-GCP standards. Avoiding common pitfalls in budgeting can be the difference between a successful trial and financial strain.

Navigate Regulatory Requirements to Optimize Trial Costs

Navigating Chile’s regulatory landscape can be a daunting task for startups aiming to conduct clinical research. Chile’s regulatory framework for research studies is overseen by the Instituto de Salud Pública (ISP), which enforces adherence to ICH-GCP standards. Startups can significantly reduce trial costs by implementing these strategic approaches:

• Understand Approval Timelines: The average approval time for clinical trials in Chile is approximately 30 business days. Planning submissions with this timeline in mind can help mitigate potential delays. Delays in approval can lead to increased timelines and a higher clinical trial cost in Chile for startups.
• Prepare Comprehensive Documentation: Ensure that all necessary documents, including the clinical research protocol, informed consent forms, and investigator brochures, are meticulously prepared to meet ISP requirements. This thorough preparation is critical for successful approval.
• Engage Local Regulatory Experts: Collaborating with local regulatory consultants, such as bioaccess®, can facilitate smoother interactions with the ISP and help navigate bureaucratic hurdles effectively. Without local expertise, startups risk facing bureaucratic challenges that could hinder their progress. Bioaccess® has successfully assisted numerous clients in achieving timely approvals, leveraging its extensive experience in the region.
• Utilize Fast-Track Pathways: Leverage Chile’s fast-track approval processes for innovative therapies, which can significantly reduce time to market and enhance the overall efficiency of study execution. For example, bioaccess® has assisted clients in accelerating their studies through these pathways, demonstrating the potential for quicker patient enrollment and lower clinical trial cost in Chile.

With bioaccess® guiding them through regulatory obligations, startups can minimize delays and costs, paving the way for a faster market entry.

Leverage Local Partnerships for Cost-Effective Trial Execution

Navigating the complexities of clinical study execution in Chile can be daunting for startups, but strategic regional collaborations offer a powerful solution. Startups should consider:

• Collaborating with Local CROs: Partnering with local Contract Research Organizations (CROs) like bioaccess® provides access to established networks, significantly reducing the time and cost associated with site selection and patient recruitment. Local CROs are well-versed in the regulatory landscape governed by the Instituto de Salud Pública (ISP), ensuring compliance with ICH-GCP standards and facilitating faster approvals, often within 30 business days.
• Engaging with Academic Institutions: Collaborating with universities and research institutions allows startups to leverage their resources, including extensive patient databases and research expertise. This collaboration can enhance recruitment efforts and improve study design, ultimately leading to more efficient execution of research.
• Building Relationships with Investigators: Cultivating strong connections with regional researchers who possess expertise in conducting medical studies is essential. Their insights can improve study protocols and enhance operational execution, ensuring that research is customized to the regional context and regulatory requirements.
• Utilizing Community Engagement: Interacting with regional communities is crucial for establishing trust and promoting involvement in research studies. Effective community outreach can lead to quicker recruitment and enhanced retention rates, which are vital for the success of research studies.

Startups often struggle with the complexities of clinical study execution, leading to delays and increased costs. By forming strategic partnerships, they can navigate these challenges more effectively, ensuring timely and cost-efficient study execution. Embracing these collaborative strategies not only streamlines operations but also positions startups to thrive in the evolving MedTech and Biopharma landscape.

Conclusion

Navigating the complexities of clinical trials can be daunting for startups, especially in a foreign market like Chile, where opportunities abound. Chile offers a unique advantage for clinical trials, particularly for first-in-human studies, due to its significantly lower costs compared to developed markets. Startups can navigate the financial landscape, use smart budgeting techniques, and build local partnerships to streamline their clinical trial processes while staying compliant and efficient. These strategies are essential for achieving successful study outcomes while maintaining financial stability.

The article outlines several best practices that can enhance cost management in clinical trials. Key strategies include:

1. Detailed budget forecasting
2. Regular budget reviews
3. Negotiating favorable contracts with vendors

Additionally, understanding the regulatory framework and engaging local experts can expedite approval processes and lower overall costs. Collaborating with local CROs, academic institutions, and community stakeholders further streamlines execution and fosters trust, ultimately enhancing patient recruitment and retention.

In conclusion, embracing these strategies not only positions startups for success but also redefines the landscape of clinical research in Latin America. By adopting these best practices, MedTech and Biopharma startups can navigate the complexities of early-stage clinical research and accelerate their timeline to market, making Chile an ideal choice for innovative clinical studies.

Frequently Asked Questions

Why is Chile considered a prime destination for clinical research, particularly for first-in-human studies?

Chile is considered a prime destination for clinical research due to significantly lower clinical trial costs, which can be 30% to 75% lower than in the U.S. and Europe. This cost efficiency is attractive for sponsors, especially startups.

What factors contribute to the lower clinical trial costs in Chile?

Key factors contributing to lower clinical trial costs in Chile include lower site costs due to reduced overhead, government incentives such as tax breaks and grants, access to regional venture capital and funding programs, and a supportive regulatory framework.

What types of government incentives are available for clinical research in Chile?

The Chilean government offers various incentives for clinical research, including tax breaks and grants aimed at innovative studies, which can help reduce the overall costs of conducting clinical trials.

How can startups access funding for clinical trials in Chile?

Startups can access funding through regional venture capital and government funding programs specifically designed to support healthcare innovations, which can enhance their financial viability for clinical trials.

What is the regulatory framework for conducting clinical trials in Chile?

The regulatory framework in Chile requires compliance with the Instituto de Salud Pública (ISP) and adherence to ICH-GCP standards. Understanding submission pathways and approval timelines is essential for study approval.

How can sponsors optimize their budgets when conducting clinical trials in Chile?

Sponsors can optimize their budgets by understanding financial dynamics and regulatory requirements, allowing for effective resource allocation to hit first-in-human milestones without exhausting capital reserves.

How do per-patient expenditures in Chile compare to those in the U.S. and Europe?

Per-patient expenditures in Latin America, including Chile, range from $15,000 to $35,000, compared to $40,000 to $75,000 in the U.S. and Europe, highlighting the financial advantages of conducting studies in Chile.

What role does bioaccess® play in navigating the financial landscape of clinical trials in Chile?

Insights from bioaccess® help MedTech startups navigate the financial landscapes effectively, ensuring successful study outcomes by optimizing budgets and understanding the regulatory environment.

List of Sources

1. Understand the Financial Landscape of Clinical Trials in Chile
   • Trends in clinical trials performed in Chile (https://scielo.cl/article_plus.php?pid=S0034-98872021000100110&tlng=en&lng=es)
   • Chile Clinical Trial Management System Market Size, Trends & Forecast Analysis (2025-2033) (https://reedintelligence.com/insights/clinical-trial-management-system-market/chile)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOoqs38GZHJgcHiGuq3l1mJ6EOqPFlA_xvgkVOi4V8PVjFF_S2NKn)
   • Chile Clinical Trial Supply & Logistics Market Size & Outlook, 2030 (https://grandviewresearch.com/horizon/outlook/clinical-trial-supply-logistics-market/chile)
   • Costs & Timelines | bioaccess® (https://bioaccessla.com/costs-and-timelines)
2. Implement Strategic Budgeting and Cost Management Techniques
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOoqY-XIdCuCM7cCI0sdrhRlG1DZP2FyMTX8Pi45ix1E8_PTyijgE)
   • How Rising Operating Costs Are Impacting LATAM Research Sites in 2024 (https://integrait.co/latam-clinical-research-sites-operating-costs-2024)
   • Strategies For Efficient Clinical Trial Budget Management (https://advarra.com/blog/strategies-for-efficient-clinical-trial-budget-management)
   • Clinical Trials Budgeting and Forecasting: Six Simple Steps to Immediately Improve Accuracy (https://clinicaltrialsarena.com/news/clinical-trials-budgeting-and-forecasting-six-simple-steps-to-immediately-improve-accuracy-5018849-2)
3. Navigate Regulatory Requirements to Optimize Trial Costs
   • Clinical Trials in Latin America (https://languageconnections.com/clinical-trials-in-latin-america)
   • Master Regulatory Compliance for Trials in Chi… | bioaccess® (https://bioaccessla.com/blog/master-regulatory-compliance-for-trials-in-chile-effectively)
   • Navigate Biopharma Clinical Trials in Chile: A Step-by-Step Guide | bioaccess® (https://bioaccessla.com/blog/navigate-biopharma-clinical-trials-in-chile-a-step-by-step-guide)
4. Leverage Local Partnerships for Cost-Effective Trial Execution
   • Best Practices for Clinical Trial Outsourcing in Chile | bioaccess® (https://bioaccessla.com/blog/best-practices-for-clinical-trial-outsourcing-in-chile)
   • What is a Contract Research Organization in Chile? | bioaccess® (https://bioaccessla.com/blog/what-is-a-contract-research-organization-in-chile)
   • How Chile Is Shaping Medical Device Clinical Trials In Latin America — bioaccess™: LATAM CRO Experts | Julio G. Martinez-Clark (https://linkedin.com/posts/juliomartinezclark_how-chile-is-shaping-medical-device-clinical-activity-7259074399159349248-2aFu)
   • Contract Research Organization Market Forecast, 2026-2033 (https://coherentmarketinsights.com/industry-reports/contract-research-organization-market)
   • Local Partnerships Are Key to Building Community Trust (https://aamchealthjustice.org/news/viewpoint/local-partnerships-key)

Introduction

Navigating the regulatory landscape for clinical trials in Chile can be daunting, yet it holds the key to unlocking swift approvals for researchers. To achieve fast clinical trial approval, understanding the intricate framework established by the Instituto de Salud Pública (ISP) is essential. Under optimal conditions, this process can take as little as 30 days.

However, how can sponsors effectively streamline their processes and enhance patient recruitment to ensure compliance while maximizing efficiency? Let’s explore a step-by-step guide to mastering the approval process, preparing necessary documentation, and implementing effective recruitment strategies in the dynamic landscape of clinical research in Chile.

Understand Regulatory Framework for Clinical Trials in Chile

Navigating the complex regulatory landscape for fast clinical trial approval in Chile can be daunting, yet it is essential for successful research outcomes. To effectively carry out clinical trials in Chile, it is crucial to navigate the regulatory framework established by the Instituto de Salud Pública (ISP) to ensure fast clinical trial approval in Chile. This procedure usually requires fast clinical trial approval in Chile, which typically takes between 30 to 90 days. Here are key regulations that can simplify your approval process:

• Law No. 20.120: Regulates studies in Chile, detailing the ethical and legal responsibilities for carrying out research involving human participants, safeguarding their rights and safety.
• Technical Norm No. 57: Offers extensive guidelines on the conduct of research studies, outlining requirements for ethical review and patient consent, which are essential for compliance.
• ICH-GCP Compliance: Adherence to the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines is critical for maintaining study integrity and participant safety, essential for regulatory acceptance.

Partnering with bioaccess® ensures fast clinical trial approval in Chile, allowing you to secure ethics approvals in just 4-8 weeks, much quicker than the usual timelines in the US and EU. Moreover, bioaccess® provides cost efficiencies and access to treatment-naïve patient populations, boosting your study’s success in Latin America. By understanding these regulations and leveraging bioaccess®, you position your study for unparalleled success in the Latin American market.

Prepare Required Documentation and Preclinical Data

Navigating the regulatory landscape in clinical research requires meticulous preparation and attention to detail. To ensure a smooth approval process with the Instituto de Salud Pública (ISP) in Chile, follow these essential steps:

1. Compile Essential Documents: Gather the following key documents:

   • A clinical study protocol that outlines the trial design, objectives, and methodology.
   • Informed consent forms that adhere to local regulations and ethical standards.
   • Investigator qualifications and detailed site information.
   • Comprehensive preclinical data demonstrating the safety and efficacy of the investigational product.

2. Submit Preclinical Data: Have you considered how crucial this data is for establishing the safety profile of your investigational product before moving to human studies? Ensure that all relevant preclinical findings are included in your submission to the ISP.

3. Ethics Committee Approval: Obtaining endorsement from a recognized Ethics Committee (Comité de Ética) linked to the research site is vital. This approval is a prerequisite for submitting your application to the ISP, and failure to secure it could lead to application rejection.

4. Prepare for Submission: All documents must be translated into Spanish and formatted according to ISP requirements. A well-organized submission package not only expedites the review process but also boosts your chances of securing timely approval.

Implement Effective Patient Recruitment Strategies

Navigating the complexities of patient recruitment in Chile is crucial for the success of clinical studies, yet many sponsors face significant challenges in this area. Here are several strategies to enhance your recruitment efforts:

1. Leverage Local Networks: Collaborate with local healthcare providers and community organizations to raise awareness about the study. Interacting with the community fosters trust and promotes involvement, which is vital for fulfilling compliance standards established by authorities such as the Instituto de Salud Pública (ISP).
2. Utilize Digital Outreach: Implement digital marketing strategies, including social media campaigns and targeted online advertisements, to reach potential participants. How can you emphasize the advantages of involvement and supply clear details regarding the study procedure? This strategy can really boost visibility and engagement, particularly in urban areas where digital access is widespread.
3. Incorporate AI in Recruitment: Utilize AI-driven predictive modeling to enhance recruitment strategies. AI can help identify eligible participants more efficiently and optimize messaging to resonate with potential recruits, thereby improving enrollment rates.
4. Patient Registries: Utilize existing patient registries to identify eligible candidates efficiently. This can streamline recruitment activities and reduce the time needed to find suitable participants, aligning with the fast clinical trial approval Chile offers, which can be as short as 30 days under the right conditions.
5. Engage with Patient Advocacy Groups: Partner with patient advocacy organizations to reach specific patient populations. These groups can assist in spreading information about the study and promoting involvement among their members, ensuring adherence to ethical standards and improving recruitment efficiency.
6. Focus on Patient Experience: Prioritize improving patient experiences throughout the recruitment process. This includes clear communication, addressing concerns, and providing support to potential participants, which can lead to higher retention rates and overall satisfaction.
7. Offer Incentives: Consider providing incentives for participation, such as travel reimbursements or health screenings, to motivate potential participants to enroll in the study. This not only improves recruitment rates but also aligns with patient-centered approaches that are increasingly emphasized in regulatory frameworks.

Embracing these strategies not only streamlines recruitment but also fosters a more patient-centered approach, ultimately enhancing the integrity of clinical research in Chile.

Execute the Clinical Trial with Compliance and Efficiency

Executing a clinical study effectively is not just important; it’s essential for ensuring compliance and safeguarding patient welfare. Follow these steps to ensure compliance and efficiency:

1. Training and Orientation: Have you conducted comprehensive training sessions for all research staff? This ensures everyone understands the protocol and compliance requirements, which is vital for upholding ICH-GCP standards.
2. Monitor Compliance: Implement robust monitoring processes to ensure adherence to ICH-GCP guidelines and local regulations, such as those set by INVIMA in Colombia or ANVISA in Brazil. Regular audits and compliance checks can help identify and address any issues early, minimizing risks associated with mismanagement of the study. Mismanagement can lead to costly delays and jeopardize patient safety.
3. Data Management: Establish a comprehensive data management plan to ensure the accuracy and integrity of collected data. Utilizing electronic data capture systems can streamline data collection and reporting, facilitating compliance with ICH-GCP documentation standards.
4. Patient Safety: Prioritize patient safety throughout the study. Diligently observe participants for adverse events and ensure that any concerns are reported swiftly to the Institutional Review Board (IRB) and Ethics Committee, following local compliance requirements. Neglecting patient safety can result in severe ethical and legal repercussions.
5. Communication: Maintain open channels of dialogue with all stakeholders, including sponsors, authorities, and study participants. Frequent updates and clear reporting build trust and enable smoother study operations, which is crucial for achieving fast clinical trial approval in Chile.

With bioaccess®’s expertise, you can achieve cost-effective clinical research solutions, including $25K savings per patient, 30% lower overall study costs, and 50% faster enrollment through pre-qualified networks and pre-negotiated site contracts. Additionally, our Global Trial Accelerators™ provide essential insights into regulatory updates and market access strategies, ensuring your trial is positioned for success. With bioaccess® at your side, you’re not just conducting a study; you’re paving the way for groundbreaking advancements in clinical research.

Conclusion

Navigating the regulatory landscape in Chile can be daunting, yet it holds the key to unlocking rapid clinical trial approvals in a burgeoning market. By understanding the regulatory framework, preparing the necessary documentation, and implementing effective patient recruitment strategies, researchers can significantly expedite the approval process and enhance the overall quality of their clinical trials.

Key insights from this guide highlight the importance of adhering to local regulations, such as:

1. Law No. 20.120
2. Technical Norm No. 57
3. ICH-GCP compliance

Thorough preparation of essential documents and preclinical data, coupled with proactive engagement in patient recruitment, can streamline the approval process and ensure ethical standards are met. Utilizing local networks, digital outreach, and patient advocacy groups can further enhance recruitment efforts, ultimately leading to a more efficient and effective clinical trial execution.

By adopting these strategies, researchers can not only expedite their trials but also drive significant advancements in patient care and treatment options.

Frequently Asked Questions

What is the regulatory framework for clinical trials in Chile?

The regulatory framework for clinical trials in Chile is primarily established by the Instituto de Salud Pública (ISP) and includes key regulations such as Law No. 20.120, which outlines ethical and legal responsibilities for research involving human participants, and Technical Norm No. 57, which provides guidelines on ethical review and patient consent.

How long does it typically take to get clinical trial approval in Chile?

The typical timeline for fast clinical trial approval in Chile ranges from 30 to 90 days.

What is Law No. 20.120?

Law No. 20.120 regulates studies in Chile, detailing the ethical and legal responsibilities for conducting research with human participants, ensuring their rights and safety are protected.

What does Technical Norm No. 57 cover?

Technical Norm No. 57 offers extensive guidelines on the conduct of research studies, including requirements for ethical review and patient consent, which are essential for compliance during clinical trials.

Why is ICH-GCP compliance important in Chile?

Adherence to the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines is critical for maintaining the integrity of the study and ensuring participant safety, which is essential for regulatory acceptance in Chile.

How can partnering with bioaccess® benefit clinical trials in Chile?

Partnering with bioaccess® can expedite the clinical trial approval process in Chile, allowing for ethics approvals in just 4-8 weeks, which is significantly quicker than typical timelines in the US and EU. Additionally, bioaccess® provides cost efficiencies and access to treatment-naïve patient populations, enhancing the success of studies in Latin America.

What advantages does conducting clinical trials in Latin America offer?

Conducting clinical trials in Latin America offers advantages such as faster approval timelines, cost efficiency, better patient recruitment opportunities, and streamlined regulatory pathways, making it an attractive region for early-stage clinical trials.

List of Sources

1. Understand Regulatory Framework for Clinical Trials in Chile
   • Number of clinical trials registered in the Chilean Institute of Public… (https://researchgate.net/figure/Number-of-clinical-trials-registered-in-the-Chilean-Institute-of-Public-Health-ISP_tbl1_351504068)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOooyu85GFsjIf3kSx5Tkgbd9ylUbPQzVCWVX6U_AGJGQ7OlbqUnJ)
   • Master Regulatory Compliance for Trials in Chi… | bioaccess® (https://bioaccessla.com/blog/master-regulatory-compliance-for-trials-in-chile-effectively)
   • 4 Best Practices for First in Human Biopharma Trials in Chile | bioaccess® (https://bioaccessla.com/blog/4-best-practices-for-first-in-human-biopharma-trials-in-chile)
2. Prepare Required Documentation and Preclinical Data
   • Preclinical Development: The Safety Hurdle Prior to Human Trials (https://americanpharmaceuticalreview.com/Featured-Articles/187349-Preclinical-Development-The-Safety-Hurdle-Prior-to-Human-Trials)
   • Navigate Medical Device Clinical Trials in Chile: A Step-by-Step Guide – cms.bioaccessla.com (https://cms.bioaccessla.com/blog/navigate-medical-device-clinical-trials-in-chile-a-step-by-step-guide)
   • Navigate Biopharma Clinical Trials in Chile: A Step-by-Step Guide | bioaccess® (https://bioaccessla.com/blog/navigate-biopharma-clinical-trials-in-chile-a-step-by-step-guide)
   • How to Conduct First-in-Human Trials in Chile: A Step-by-Step Guide | bioaccess® (https://bioaccessla.com/blog/how-to-conduct-first-in-human-trials-in-chile-a-step-by-step-guide)
3. Implement Effective Patient Recruitment Strategies
   • Precision, Relevance and Prediction: The Future of Clinical Trial Recruitment (https://gcihealth.com/2026/01/22/precision-relevance-and-prediction-the-future-of-clinical-trial-recruitment)
   • Digital Marketing Revolutionizes Patient Recruitment | ImageBloom (https://imagebloom.com/digital-marketing-revolutionizes-clinical-trial-recruitment)
   • Looking Back at SCOPE 2026: Recruitment Trends | Citeline (https://citeline.com/en/resources/recap-of-recruitment-trends-at-scope)
   • Patient Recruitment for Clinical Trials: Strategies That Actually Work (https://kapsuletech.com/blog/patient-recruitment-clinical-trials)
4. Execute the Clinical Trial with Compliance and Efficiency
   • Well-Trained Staff Can Improve Your Clinical Trial Outcomes (https://taskacademy.org/how-well-trained-staff-can-improve-your-clinical-trial-outcomes)
   • Ensuring Quality Clinical Trials with ICH-GCP Compliance (https://statswork.com/insights/articles/statistical-programming-biostatistics/ich-gcp-compliance-clinical-trials)
   • Managing Clinical Research Teams: Leadership Strategies for PIs (https://ccrps.org/clinical-research-blog/managing-clinical-research-teams-leadership-strategies-for-pis)

Introduction

The cardiovascular clinical trial landscape in Chile is rife with complexities that can either hinder or propel sponsors toward success. With a regulatory framework designed to protect participants while promoting research, understanding the nuances of approval processes, patient recruitment strategies, and early feasibility studies is crucial for success.

What strategies can sponsors adopt to turn these local advantages into tangible benefits for their trial outcomes? By mastering these local intricacies, sponsors can significantly improve their trial outcomes and accelerate their market entry.

Understand Regulatory Frameworks for Clinical Trials in Chile

Navigating Chile’s regulatory landscape for research studies can be complex, yet it is essential for successful outcomes. The framework established by Law No. 20.120 governs research involving human subjects, with the Instituto de Salud Pública (ISP) overseeing the approval process, which typically takes between 30 to 90 days. Adhering to International Council for Harmonisation Good Clinical Practice (ICH-GCP) standards is vital, ensuring that studies are conducted ethically and scientifically sound.

Navigating the approval process can be daunting without a clear understanding of submission pathways. This involves preparing necessary documentation such as the study protocol and informed consent forms. This understanding not only accelerates approvals but also enhances the trustworthiness of your research data, making it more acceptable to international authorities like the FDA.

Law No. 20.120 has led to significant improvements in the research landscape, including enhanced protections and a focus on aligning studies with local health needs. Successful approvals of research studies under this law illustrate its effectiveness in promoting investigation while safeguarding participant welfare and ethical benchmarks. By mastering these regulations, sponsors can unlock the full potential of their research initiatives in Latin America.

Implement Early Feasibility Studies to Optimize Trial Design

Early feasibility studies (EFS) are essential for evaluating the safety and functionality of new medical devices or therapies, setting the stage for successful clinical evaluations. In the country, conducting an EFS allows sponsors to gather preliminary data on device performance and patient safety, which is crucial for enhancing the design of subsequent studies. These studies generally enroll a limited number of participants, often ten or fewer, and focus on specific endpoints essential for submissions to authorities.

Sponsors can efficiently execute EFS by leveraging the diverse patient population and local expertise in the region. This often leads to results that are significantly faster than those from traditional trial designs. This faster process reduces risks and boosts the chances of approval by delivering strong preliminary data that backs the safety and effectiveness of the intervention.

The oversight framework in Chile, supported by agencies such as the Instituto de Salud Pública (ISP), facilitates a streamlined pathway for EFS, allowing for reduced preclinical data requirements compared to pivotal studies. This flexibility is particularly advantageous for MedTech and Biopharma companies aiming to navigate compliance challenges while optimizing trial design.

Furthermore, the EFS program promotes ongoing communication with oversight bodies, which can result in timely adjustments of clinical protocols based on early findings. By adopting best practices in EFS, sponsors can enhance their regulatory submissions, speeding up the journey to market for innovative medical technologies. Significantly, conducting studies in Latin America can result in considerable cost reductions, with pre-negotiated site contracts providing $25K savings per patient and overall expenses being 30% lower than in other areas. Moreover, the strategic benefits of conducting studies in Colombia, Brazil, and Mexico further boost the potential for successful early phase research.

Develop Targeted Patient Recruitment Strategies for Effective Participation

In the competitive landscape of first-in-human research, efficient patient enrollment is not just important; it’s essential for success. Effective strategies include:

• Leveraging patient registries.
• Partnering with local healthcare providers.
• Employing digital outreach methods to significantly raise awareness about the study.

Imagine facing a staggering 80% of studies delayed due to recruitment issues, emphasizing the necessity for focused strategies.

To build trust and encourage participation, it’s essential to address barriers like language and cultural differences. Customizing recruitment messages to connect with the intended demographic can lead to enhanced enrollment rates, ensuring studies are completed on schedule and within budget. For instance, successful patient recruitment examples in a cardiovascular clinical trial in Chile have shown that community engagement initiatives, such as informational sessions and partnerships with local advocacy groups, can yield higher participation rates.

Furthermore, adherence to local compliance necessities, such as those established by the Instituto de Salud Pública (ISP) and conformity to ICH-GCP standards, is crucial for preserving the integrity of the study process. By implementing these strategies, sponsors can turn the tide on recruitment delays, enhancing their chances of meeting recruitment goals and obtaining the necessary data for submission processes. Ultimately, the right strategies can transform recruitment challenges into opportunities for groundbreaking research.

Leverage Local Clinical Trial Sites for Faster Execution

For sponsors embarking on first-in-human studies, local experimental sites in the region present a compelling advantage. These sites have established relationships with local regulatory authorities, such as the Instituto de Salud Pública (ISP) and the Agencia Nacional de Medicamentos (ANAMED), along with a deep understanding of regional patient demographics. This knowledge can significantly expedite patient recruitment and retention. Did you know that in this region, the approval process for medical device clinical evaluations takes just 4 to 8 weeks? Compare that to the six to nine months it takes in Brazil and Colombia.

Additionally, conducting studies in the region is cost-effective; per-patient expenses range from $15,000 to $35,000, significantly lower than the $40,000 to $75,000 typically observed in the U.S. and EU. Ethics committee fees in Chile also reflect this trend, ranging from $500 to $3,000, which is considerably less than the fees in developed markets. When sponsors choose pre-qualified sites that meet ICH-GCP standards, they can conduct their studies efficiently and ethically, ensuring high-quality data integrity.

Choosing local sites speeds up study execution. It also boosts the quality of the clinical data collected. With site readiness attainable in as little as 30 days, sponsors can take advantage of the swift activation timelines that the region provides. This method not only accelerates the evaluation process but also establishes Chile as a rising center for medical device research in Latin America, highlighting its ability to facilitate a variety of complex medical device studies. Additionally, sponsors can potentially save $25K per patient and benefit from an overall trial cost reduction of 30%, allowing for reinvestment into R&D or future funding milestones. By leveraging these local advantages, sponsors can not only enhance their research outcomes but also position themselves strategically in the evolving Medtech landscape.

Conclusion

Navigating the complexities of regulatory frameworks and patient recruitment can be daunting for sponsors in cardiovascular clinical trials in Chile. By capitalizing on Chile’s distinct advantages, sponsors can optimize their research initiatives, ensuring both ethical compliance and scientific integrity. Emphasizing the importance of local regulations, such as Law No. 20.120, and adherence to ICH-GCP standards lays the groundwork for robust and trustworthy clinical research.

It’s clear that early feasibility studies are crucial for refining trial designs, and targeted patient recruitment strategies play a vital role in overcoming enrollment challenges. By utilizing local clinical trial sites, sponsors can significantly reduce costs and expedite study execution, thereby enhancing the overall efficiency of their clinical trials. The integration of these best practices not only streamlines the approval process but also fosters a conducive environment for innovative medical research.

In conclusion, by embracing these strategies, sponsors can not only navigate challenges but also position themselves at the forefront of medical innovation in Latin America. Prioritizing regulatory compliance, optimizing trial designs through early feasibility studies, and implementing effective recruitment strategies will transform potential obstacles into opportunities for groundbreaking advancements in healthcare.

Frequently Asked Questions

What is the primary law governing clinical trials in Chile?

The primary law governing clinical trials in Chile is Law No. 20.120, which regulates research involving human subjects.

Which organization oversees the approval process for clinical trials in Chile?

The Instituto de Salud Pública (ISP) oversees the approval process for clinical trials in Chile.

How long does the approval process for clinical trials typically take in Chile?

The approval process for clinical trials in Chile typically takes between 30 to 90 days.

What standards must be adhered to when conducting clinical trials in Chile?

Adherence to the International Council for Harmonisation Good Clinical Practice (ICH-GCP) standards is vital for conducting clinical trials ethically and scientifically sound in Chile.

What documentation is required for submitting a clinical trial in Chile?

Necessary documentation for submitting a clinical trial in Chile includes the study protocol and informed consent forms.

How does understanding the regulatory framework benefit clinical trial sponsors?

A clear understanding of the regulatory framework accelerates approvals and enhances the trustworthiness of research data, making it more acceptable to international authorities like the FDA.

What improvements has Law No. 20.120 brought to the research landscape in Chile?

Law No. 20.120 has led to significant improvements, including enhanced protections for participants and a focus on aligning studies with local health needs.

Why is mastering the regulatory framework important for sponsors conducting research in Latin America?

Mastering the regulatory framework allows sponsors to unlock the full potential of their research initiatives, facilitating faster patient recruitment and more efficient clinical trial operations in Latin America.

List of Sources

1. Understand Regulatory Frameworks for Clinical Trials in Chile
   • Trends in clinical trials performed in Chile (https://scielo.cl/article_plus.php?pid=S0034-98872021000100110&tlng=en&lng=es)
   • 4 Best Practices for First in Human Biopharma Trials in Chile | bioaccess® (https://bioaccessla.com/blog/4-best-practices-for-first-in-human-biopharma-trials-in-chile)
   • Best Practices for Selecting Investigator Sites in Chile for Clinical Trials | bioaccess® (https://bioaccessla.com/blog/best-practices-for-selecting-investigator-sites-in-chile-for-clinical-trials)
   • leaux.net (https://leaux.net/URLS/Synopses/F29314493B6746358A05ACFE4345F9B1.html)
2. Implement Early Feasibility Studies to Optimize Trial Design
   • Early feasibility studies on devices: “doing it sooner” to avoid trial failure | Meditrial (https://meditrial.net/2022/09/early-feasibility-studies-on-devices-doing-it-sooner-to-avoid-trial-failure)
   • Clinical trials by start date Chile 1999-2024| Statista (https://statista.com/statistics/1560150/chile-number-new-clinical-trials?srsltid=AfmBOopE4ubow09F75P45cmMxVErUhyMTgNDIvHT3KC8SVNJd6uBlU3y)
   • Early Feasibility Studies (EFS) Program (https://fda.gov/medical-devices/investigational-device-exemption-ide/early-feasibility-studies-efs-program)
   • Should You Conduct Your Medical Device Clinical Trial In Latin America? – Journal for Clinical Studies (https://journalforclinicalstudies.com/conduct-medical-device-clinical-trial-latin-america)
   • Master Early Phase Clinical Trials in Chile: Key Strategies and Insights | bioaccess® (https://bioaccessla.com/blog/master-early-phase-clinical-trials-in-chile-key-strategies-and-insights)
3. Develop Targeted Patient Recruitment Strategies for Effective Participation
   • Seven Best Practices For Clinical Trial Patient Recruitment (https://openclinica.com/blog/seven-patient-recruitment-best-practices-used-by-leading-research-studies)
   • Patient Recruitment Strategies for Trials | CCRPS (https://ccrps.org/clinical-research-blog/patient-recruitment-strategies-for-clinical-trials)
   • Patient Recruitment for Clinical Trials: Strategies That Actually Work (https://kapsuletech.com/blog/patient-recruitment-clinical-trials)
   • Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11348161)
   • 3 Patient Recruitment Strategies in Clinical Trials (https://clariness.com/resource/3-patient-recruitment-strategies-in-clinical-trials)
4. Leverage Local Clinical Trial Sites for Faster Execution
   • Clinical Trials Quotes (2 quotes) (https://goodreads.com/quotes/tag/clinical-trials)
   • How Chile Is Shaping Medical Device Clinical Trials In Latin America (https://meddeviceonline.com/doc/how-chile-is-shaping-medical-device-clinical-trials-in-latin-america-0001)
   • Costs & Timelines | bioaccess® (https://bioaccessla.com/costs-and-timelines)
   • Chile Clinical Trial Supply & Logistics Market Size & Outlook, 2030 (https://grandviewresearch.com/horizon/outlook/clinical-trial-supply-logistics-market/chile)